Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1111763

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1111763

Inhalable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

PUBLISHED:
PAGES: 173 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 8000
PDF (Global License)
USD 12000

Add to Cart

GlobalData's Medical Devices sector report, "Inhalable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Inhalable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inhalable Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalable Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalable Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1393EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Inhalable Drug Delivery Overview

3 Products under Development

  • 3.1 Inhalable Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Inhalable Drug Delivery - Pipeline Products by Segment
  • 3.3 Inhalable Drug Delivery - Pipeline Products by Territory
  • 3.4 Inhalable Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Inhalable Drug Delivery - Ongoing Clinical Trials

4 Inhalable Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Inhalable Drug Delivery - Pipeline Products by Stage of Development

5 Inhalable Drug Delivery Companies and Product Overview

  • 5.1 Acerus Pharmaceuticals Corp Company Overview
  • 5.2 Acorda Therapeutics Inc Company Overview
  • 5.3 Actervis GmbH Company Overview
  • 5.4 Aerami Therapeutics Inc Company Overview
  • 5.5 Aerophase Inc Company Overview
  • 5.6 Alexza Pharmaceuticals Inc Company Overview
  • 5.7 Baxter International Inc Company Overview
  • 5.8 Bellerophon Therapeutics Inc Company Overview
  • 5.9 Breath Therapeutics Holding BV Company Overview
  • 5.10 California Northstate University College of Medicine Company Overview
  • 5.11 Canigma A.L LTD Company Overview
  • 5.12 Cipla Ltd Company Overview
  • 5.13 Department of Biomedical Engineering Columbia University Company Overview
  • 5.14 Edixomed Ltd Company Overview
  • 5.15 Engage Therapeutics Inc Company Overview
  • 5.16 iDTx Systems, Inc. Company Overview
  • 5.17 Impel Pharmaceuticals Inc Company Overview
  • 5.18 Inhalation Sciences Sweden AB Company Overview
  • 5.19 Invero Pharma LLC Company Overview
  • 5.20 Jupiter Research LLC Company Overview
  • 5.21 Kanabo Research Ltd Company Overview
  • 5.22 Lupin Pharmaceuticals Inc Company Overview
  • 5.23 Mallinckrodt Plc Company Overview
  • 5.24 Medical Developments International Ltd Company Overview
  • 5.25 Medspray BV Company Overview
  • 5.26 Monash University Company Overview
  • 5.27 Nemera La Verpilliere Company Overview
  • 5.28 Next Safety, Inc. Company Overview
  • 5.29 Nobilis Therapeutics Inc Company Overview
  • 5.30 OncoSec Medical Inc Company Overview
  • 5.31 Pharmosa Biopharm Inc Company Overview
  • 5.32 Rhinomed Ltd Company Overview
  • 5.33 Risproly Company Overview
  • 5.34 Rutgers Cancer Institute of New Jersey Company Overview
  • 5.35 Sandoz International GmbH Company Overview
  • 5.36 Seng Vital International GmbH Company Overview
  • 5.37 Shenzhen Smoore Technology Ltd Company Overview
  • 5.38 Sino Biopharmaceutical Ltd Company Overview
  • 5.39 Technology Commercialization Partners LLC Company Overview
  • 5.40 Tetra Bio-Pharma Inc Company Overview
  • 5.41 Teva Pharmaceutical Industries Ltd Company Overview
  • 5.42 Texas Tech University Health Sciences Center Company Overview
  • 5.43 Third Pole Inc Company Overview
  • 5.44 Tiziana Life Sciences PLC Company Overview
  • 5.45 Torrent Pharmaceuticals Ltd Company Overview
  • 5.46 University Hospital Southampton NHS Foundation Trust Company Overview
  • 5.47 University of Texas Health Science Center at Houston Company Overview
  • 5.48 Vectura Group Plc Company Overview
  • 5.49 Veoli Ltd Company Overview
  • 5.50 Vero Biotech LLC Company Overview
  • 5.51 Via Therapeutics LLC Company Overview
  • 5.52 Virpax Pharmaceuticals Inc Company Overview
  • 5.53 VistaGen Therapeutics Inc Company Overview
  • 5.54 VitalMIST Company Overview
  • 5.55 Wellfully Ltd Company Overview
  • 5.56 Windtree Therapeutics Inc Company Overview

6 Inhalable Drug Delivery- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Product Code: GDME1393EPD

List of Tables

List of Tables

  • Inhalable Drug Delivery - Pipeline Products by Stage of Development
  • Inhalable Drug Delivery - Pipeline Products by Segment
  • Inhalable Drug Delivery - Pipeline Products by Territory
  • Inhalable Drug Delivery - Pipeline Products by Regulatory Path
  • Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
  • Inhalable Drug Delivery - Ongoing Clinical Trials
  • Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
  • Inhalable Drug Delivery - Pipeline Products by Stage of Development
  • Acerus Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
  • No-Touch Applicator Device - Product Status
  • No-Touch Applicator Device - Product Description
  • Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Drug Delivery Device - Neonatal Respiratory Distress Syndrome (RDS) - Product Status
  • Drug Delivery Device - Neonatal Respiratory Distress Syndrome (RDS) - Product Description
  • Actervis GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Inhaluxe - Product Status
  • Inhaluxe - Product Description
  • Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • FOX Mesh Nebulizer - Pulmonary Arterial Hypertension - Product Status
  • FOX Mesh Nebulizer - Pulmonary Arterial Hypertension - Product Description
  • Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Aerosol-Delivery System - Lung Cancer - Product Status
  • Aerosol-Delivery System - Lung Cancer - Product Description
  • Alexza Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Staccato Fentanyl Inhalation System - Product Status
  • Staccato Fentanyl Inhalation System - Product Description
  • Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ProMaxx Microsphere - Product Status
  • ProMaxx Microsphere - Product Description
  • Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • INOpulse - Product Status
  • INOpulse - Product Description
  • Bellerophon Therapeutics Inc - Ongoing Clinical Trials Overview
  • INOpulse - A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated with Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
  • INOpulse - An Open-label Long-term Safety Study of Inhaled Nitric Oxide (iNO) for PAH for Subjects in the PULSE-PAH-006 and PULSE-PAH-004 Studies Who Continue to Need iNO Therapy
  • INOpulse - Expanded Access: Pulsed, Inhaled Nitric Oxide (iNO) for the Treatment of Patients With Serious Disease or Conditions Associated With Pulmonary Hypertension
  • INOpulse - INOvation-2 Clinical Study of INOpulse Device
  • INOpulse - Phase IIb Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects in Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease (PH-COPD)
  • INOpulse - Pivotal Phase 3 Study Evaluate the INOpulse for the Treatment of Pulmonary Hypertension Associated with Pulmonary Fibrosis
  • Breath Therapeutics Holding BV Pipeline Products & Ongoing Clinical Trials Overview
  • Lung-Targeted BOS Device - Product Status
  • Lung-Targeted BOS Device - Product Description
  • Breath Therapeutics Holding BV - Ongoing Clinical Trials Overview
  • Lung-Targeted BOS Device - A Phase IIa Multi-center, Randomized, Single-blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation
  • Lung-Targeted BOS Device - A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung Transplant
  • Lung-Targeted BOS Device - A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung Transplant
  • Lung-Targeted BOS Device - A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung Transplant
  • California Northstate University College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Drug Delivery System - PAH - Product Status
  • Drug Delivery System - PAH - Product Description
  • Canigma A.L LTD Pipeline Products & Ongoing Clinical Trials Overview
  • Vaporiser Device - Product Status
  • Vaporiser Device - Product Description
  • Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Complex Inhaler - Product Status
  • Complex Inhaler - Product Description
  • Smart Inhaler - Product Status
  • Smart Inhaler - Product Description
  • Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Hava - Product Status
  • Hava - Product Description
  • Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • NOx System - VAP - Product Status
  • NOx System - VAP - Product Description
  • Engage Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Staccato Alprazolam - Product Status
  • Staccato Alprazolam - Product Description
  • iDTx Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • GoPilot - Product Status
  • GoPilot - Product Description
  • Impel Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • INP105 - Product Status
  • INP105 - Product Description
  • POD Device - Product Status
  • POD Device - Product Description
  • Impel Pharmaceuticals Inc - Ongoing Clinical Trials Overview
  • INP105 - A Phase 2a, Randomized, Double-blind, Placebo-controlled, Single Dose, 2-way, 2-period Crossover Safety and Exploratory Efficacy Study of INP105 (POD-OLZ) for the Acute Treatment of Agitation in Adolescents with Autism Spectrum Disorder
  • Inhalation Sciences Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
  • PreciseInhale System - Product Status
  • PreciseInhale System - Product Description
  • Inhalation Sciences Sweden AB - Ongoing Clinical Trials Overview
  • PreciseInhale System - A Clinical Validation Study of PreciseInhale System in Healthy Volunteers
  • Invero Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
  • XENEX - Product Status
  • XENEX - Product Description
  • Invero Pharma LLC - Ongoing Clinical Trials Overview
  • XENEX - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome: XePOHCAS
  • Jupiter Research LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Liquid9 - Product Status
  • Liquid9 - Product Description
  • Kanabo Research Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Next Generation Smart VapePod MD Vaporizer - Product Status
  • Next Generation Smart VapePod MD Vaporizer - Product Description
  • VapePod - Product Status
  • VapePod - Product Description
  • Kanabo Research Ltd - Ongoing Clinical Trials Overview
  • VapePod - Study to Evaluate the Bioavailability and Efficacy for Kanabo's Cannabis Inhalation Formulas in Conjunction with VapePod
  • Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Soft-Mist Inhalation Device - Product Status
  • Soft-Mist Inhalation Device - Product Description
  • Mallinckrodt Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Next Generation Inomax Evolve - Product Status
  • Next Generation Inomax Evolve - Product Description
  • Medical Developments International Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Penthrox Inhaler - Product Status
  • Penthrox Inhaler - Product Description
  • Penthrox Inhaler - Paediatric - Product Status
  • Penthrox Inhaler - Paediatric - Product Description
  • Medical Developments International Ltd - Ongoing Clinical Trials Overview
  • Penthrox Inhaler - An Open-Label Study to Assess the Efficacy and Safety of Low Dose Methoxyflurane (Penthrox) for Pain Control During Outpatient Aesthetic Surgeries and Facial Filler Injections
  • Penthrox Inhaler - Methoxyflurane at Moderate High Altitudes for Pain Management: A Randomized, Double-blind, Cross-over Study
  • Penthrox Inhaler - Prospective, Multicenter Trial of Methoxyflurane for Acute Trauma-related Pain in Helicopter Emergency Medical Systems and Hostile Environments: METEORA
  • Penthrox Inhaler - Reduction of Anterior Shoulder Dislocation Facilitated by Inhaled Low Dose Methoxyflurane - A Pilot Study
  • Medspray BV Pipeline Products & Ongoing Clinical Trials Overview
  • Device 0075 - Product Status
  • Device 0075 - Product Description
  • Product 0070 - Product Status
  • Product 0070 - Product Description
  • Product 0077 - Product Status
  • Product 0077 - Product Description
  • Monash University Pipeline Products & Ongoing Clinical Trials Overview
  • Nebuliser - Product Status
  • Nebuliser - Product Description
  • Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
  • CUPIDO - Product Status
  • CUPIDO - Product Description
  • Next Safety, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Pulmonary Drug Delivery Device - Product Status
  • Pulmonary Drug Delivery Device - Product Description
  • Nobilis Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Zephyrus - Product Status
  • Zephyrus - Product Description
  • Nobilis Therapeutics Inc - Ongoing Clinical Trials Overview
  • Zephyrus - A Double-blind, Randomized, Placebo-controlled Trial of Xenon Inhalation for Treatment of Patients with Panic Disorder
  • Zephyrus - A Double-blind, Randomized, Placebo-controlled Trial of Xenon Inhalation for Treatment of Patients with Posttraumatic Stress Disorder
  • OncoSec Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • NeoPulse - Skin Cancer - Product Status
  • NeoPulse - Skin Cancer - Product Description
  • Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview
  • L606 Inhalation System - Product Status
  • L606 Inhalation System - Product Description
  • L608 Inhalation System - Product Status
  • L608 Inhalation System - Product Description
  • Pharmosa Biopharm Inc - Ongoing Clinical Trials Overview
  • L606 Inhalation System - A Phase 3, 2-Part, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects with Pulmonary Arterial Hypertension Previously Stabilized on Inhaled Treprostinil Products
  • Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Pronto Anxiety - Product Status
  • Pronto Anxiety - Product Description
  • Pronto Migraine - Product Status
  • Pronto Migraine - Product Description
  • Pronto Sleep Plus - Product Status
  • Pronto Sleep Plus - Product Description
  • Risproly Pipeline Products & Ongoing Clinical Trials Overview
  • Drug Delivery Device - Asthma - Product Status
  • Drug Delivery Device - Asthma - Product Description
  • Drug Delivery Device - CNS Disease - Product Status
  • Drug Delivery Device - CNS Disease - Product Description
  • Drug Delivery Device - COPD - Product Status
  • Drug Delivery Device - COPD - Product Description
  • Rutgers Cancer Institute of New Jersey Pipeline Products & Ongoing Clinical Trials Overview
  • Pulmonary Drug Delivery System - Product Status
  • Pulmonary Drug Delivery System - Product Description
  • Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • FreePath Drug Delivery System - Product Status
  • FreePath Drug Delivery System - Product Description
  • Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Medihale 2 - Product Status
  • Medihale 2 - Product Description
  • Medihale Slim Line 1 - Product Status
  • Medihale Slim Line 1 - Product Description
  • Shenzhen Smoore Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Inhalation Delivery Device - Product Status
  • Inhalation Delivery Device - Product Description
  • Sino Biopharmaceutical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • SFT-1001 - Product Status
  • SFT-1001 - Product Description
  • SFT-1002 - Product Status
  • SFT-1002 - Product Description
  • SFT-1003 - Product Status
  • SFT-1003 - Product Description
  • SFT-1004 - Product Status
  • SFT-1004 - Product Description
  • Technology Commercialization Partners LLC Pipeline Products & Ongoing Clinical Trials Overview
  • iNO Delivery System - Product Status
  • iNO Delivery System - Product Description
  • Tetra Bio-Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CAUMZ-kit - Product Status
  • CAUMZ-kit - Product Description
  • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Digihaler - Product Status
  • Digihaler - Product Description
  • QVAR Digihaler - Product Status
  • QVAR Digihaler - Product Description
  • Texas Tech University Health Sciences Center Pipeline Products & Ongoing Clinical Trials Overview
  • Inhalable Nanoparticle System - Product Status
  • Inhalable Nanoparticle System - Product Description
  • Third Pole Inc Pipeline Products & Ongoing Clinical Trials Overview
  • eNOcare - Product Status
  • eNOcare - Product Description
  • eNOfit - Product Status
  • eNOfit - Product Description
  • Tiziana Life Sciences PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Nasal Drug Delivery Device - Product Status
  • Nasal Drug Delivery Device - Product Description
  • Torrent Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Mecobalamine Nasal Spray - Product Status
  • Mecobalamine Nasal Spray - Product Description
  • University Hospital Southampton NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
  • Covsurf Drug Delivery System - Product Status
  • Covsurf Drug Delivery System - Product Description
  • University Hospital Southampton NHS Foundation Trust - Ongoing Clinical Trials Overview
  • Covsurf Drug Delivery System - A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19
  • University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
  • Pedinap - Product Status
  • Pedinap - Product Description
  • Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
  • FOX Vibrating Mesh Nebulizer - Product Status
  • FOX Vibrating Mesh Nebulizer - Product Description
  • VR475 Combination Device - Product Status
  • VR475 Combination Device - Product Description
  • VR647 - Product Status
  • VR647 - Product Description
  • Vectura Group Plc - Ongoing Clinical Trials Overview
  • VR647 - A Phase I Clinical Study of VR-647
  • VR647 - A Phase I Clinical Study of VR-647 in Adult Asthma Subjects
  • VR647 - Phase II Pharmacokinetic Study of VR-647 in Children
  • VR647 - Phase III Study of VR-647
  • Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Cannabis Inhaler Device - Product Status
  • Cannabis Inhaler Device - Product Description
  • Vero Biotech LLC Pipeline Products & Ongoing Clinical Trials Overview
  • GeNOsyl Acute DS - Product Status
  • GeNOsyl Acute DS - Product Description
  • GeNOSYL Chronic DS - Product Status
  • GeNOSYL Chronic DS - Product Description
  • NITROSYL System - Product Status
  • NITROSYL System - Product Description
  • Via Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Inhaled Delivery System - Product Status
  • Inhaled Delivery System - Product Description
  • Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • NES100 - Product Status
  • NES100 - Product Description
  • VistaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • PH94B Neuroactive Nasal Spray - Product Status
  • PH94B Neuroactive Nasal Spray - Product Description
  • VistaGen Therapeutics Inc - Ongoing Clinical Trials Overview
  • PH94B Neuroactive Nasal Spray - A Phase IIa Double-blind, Placebo-controlled, Parallel Study of PH94B Nasal Spray in the Treatment of Adjustment Disorder with Anxiety
  • PH94B Neuroactive Nasal Spray - A Phase III Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of PH94B Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects with Social Anxiety Disorder
  • VitalMIST Pipeline Products & Ongoing Clinical Trials Overview
  • VitalMIST - Product Status
  • VitalMIST - Product Description
  • Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Nebulizer - Product Status
  • Nebulizer - Product Description
  • Windtree Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Aerosol Drug Delivery Device - Acute Lung Injury - Product Status
  • Aerosol Drug Delivery Device - Acute Lung Injury - Product Description
  • AEROSURF - Product Status
  • AEROSURF - Product Description
  • Capillary Aerosol Generator (CAG) - Product Status
  • Capillary Aerosol Generator (CAG) - Product Description
  • Glossary

List of Figures

List of Figures

  • Inhalable Drug Delivery - Pipeline Products by Stage of Development
  • Inhalable Drug Delivery - Pipeline Products by Segment
  • Inhalable Drug Delivery - Pipeline Products by Territory
  • Inhalable Drug Delivery - Pipeline Products by Regulatory Path
  • Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
  • Inhalable Drug Delivery - Ongoing Clinical Trials
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!